|
|
|
Volumn 17, Issue 97, 2008, Pages 188-
|
|
Vildagliptin and vildagliptin/metformin: Same limited efficacy as sitagliptin in type 2 diabetes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EUCREAS;
GLIBENCLAMIDE;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
METFORMIN;
PLACEBO;
SITAGLIPTIN;
UNCLASSIFIED DRUG;
VILDAGLIPTIN;
ARTICLE;
ATRIOVENTRICULAR BLOCK;
CLINICAL TRIAL;
DRUG EFFICACY;
EDEMA;
EUROPEAN UNION;
GLYCEMIC CONTROL;
HEADACHE;
HUMAN;
INFECTION;
LIVER DISEASE;
MORBIDITY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RISK BENEFIT ANALYSIS;
SKIN ULCER;
ADAMANTANE;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG APPROVAL;
DRUG COMBINATIONS;
EUROPE;
HUMANS;
METFORMIN;
NITRILES;
PYRROLIDINES;
|
|
EID: 67649391016
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|